NCT02062736

Brief Summary

The purpose of the study ( observational and prospective ) is to evaluate the efficacy and tolerability of the methadone maintenance treatment in patients addicted to heroin. The efficacy and tolerability are assessed by correlating to the adequacy of the dosage of methadone. The patients will be observed for two years.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Feb 2010

Longer than P75 for all trials

Geographic Reach
1 country

5 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2010

Completed
4 years until next milestone

First Submitted

Initial submission to the registry

January 24, 2014

Completed
8 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2014

Completed
13 days until next milestone

First Posted

Study publicly available on registry

February 14, 2014

Completed
15 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2014

Completed
Last Updated

April 28, 2016

Status Verified

April 1, 2016

Enrollment Period

4 years

First QC Date

January 24, 2014

Last Update Submit

April 27, 2016

Conditions

Keywords

methadoneheroin addictionmethadone maintenance treatmentadequate dosage of methadone

Outcome Measures

Primary Outcomes (1)

  • the efficacy of the methadone maintenance treatment in addicted heroin patients, evaluating the correlation among efficacy and adequate dosage in comparison to not adequate dosage.

    2 years ( 7 visits for patient )

Secondary Outcomes (3)

  • QT prolongation risk in patients addicted to heroin who have undertaken MMT

    2 years ( evaluation at t0, t0 +6/12/18/24 months)

  • psychopathological status of observed patients in correlation with the adequate dosage in comparison to not adequate dosages

    2 years ( 7 visits for patient )

  • pharmacoeconomic condition correlated with the adequate dosage in comparison to not adequate dosage.

    2 years ( 7 visits for patient )

Study Arms (1)

pts addicted to heroin in MMT

patients addicted to heroin who have undertaken methadone maintenance treatment

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

patients addicted to heroin and who have undertaken a methadone maintenance treatment, observed in involved centres.

You may qualify if:

  • Both sexes
  • Over 18 years of age
  • Patients with a diagnosis of heroin addiction according to ICD-10 (International Classification of Diseases)
  • Patients who have undertaken a methadone maintenance treatment
  • Adhesion to observational study by signing informed consent.

You may not qualify if:

  • Inability to follow the observation
  • Diagnosis of decompensated psychotic disorders

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (5)

Dipartimento DSM, DP area Dipendenze Patologiche, UOSD Ser.T BO est

Bologna, BO, 40138, Italy

Location

Dipartimento delle Dipendenze ASL MI 2

Milan, MI, 20063, Italy

Location

Servizio dipendenze, AUSL

Pescara, PE, 65124, Italy

Location

Dipartimento Dipendenze, ASL TO 2

Torino, TO, 10149, Italy

Location

U.O.C. Ser.T ASL RMC, Distretto 11

Roma, 00178, Italy

Location

Related Publications (1)

  • D'Egidio PF, Bignamini E, De Vivo E, Leonardi C, Pieri MC, Gonzalez-Saiz F, Lucchini A; METODO Study Team. METODO, a prospective observational study to assess the efficacy and tolerability of methadone in heroin-addicted patients undergoing a methadone maintenance treatment: preliminary results at baseline evaluation. Subst Use Misuse. 2013 Dec;48(14):1530-40. doi: 10.3109/10826084.2013.800886. Epub 2013 Jul 3.

    PMID: 23822738BACKGROUND

MeSH Terms

Conditions

Heroin Dependence

Condition Hierarchy (Ancestors)

Opioid-Related DisordersNarcotic-Related DisordersSubstance-Related DisordersChemically-Induced DisordersMental Disorders

Study Officials

  • Donatella Mariani

    Solaris CRO

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 24, 2014

First Posted

February 14, 2014

Study Start

February 1, 2010

Primary Completion

February 1, 2014

Study Completion

March 1, 2014

Last Updated

April 28, 2016

Record last verified: 2016-04

Locations